Cargando…

Comparison of McAuley/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus

OBJECTIVE: To estimate the prevalence of insulin resistant syndrome (IRS) among newly diagnosed patients with type 2 diabetes and to test their validity against two indices of insulin resistance (IR). MATERIALS AND METHODS: Prevalence of IRS was estimated according to the criteria used by ATP III in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hettihewa, L. M., Weerarathna, T. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157124/ https://www.ncbi.nlm.nih.gov/pubmed/21897708 http://dx.doi.org/10.4103/0976-500X.83280

Ejemplares similares

Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy
por: Hettihewa, L. M., et al.
Publicado: (2008)

The insulin sensitivity Mcauley index (MCAi) is associated with 40-year cancer mortality in a cohort of men and women free of diabetes at baseline
por: Moshkovits, Yonatan, et al.
Publicado: (2022)

A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions
por: Herath, H. M. M., et al.
Publicado: (2018)

Fasting Indicators of Insulin Sensitivity: Effects of Ethnicity and Pubertal Status
por: Adam, Tanja C., et al.
Publicado: (2011)

Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2023)

Limitations of fasting indices in the measurement of insulin sensitivity in Afro-Caribbean adults
por: Thompson, Debbie S, et al.
Publicado: (2014)

Modern insulin and insulin therapy in diabetes mellitus.
por: Montgomery, D. A.
Publicado: (1978)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Impact of 3-year changes in fasting insulin and insulin resistance indices on incident hypertension: Tehran lipid and glucose study
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2019)

Correlation of insulin resistance by various methods with fasting insulin in obese
por: Panag, Kanwal Mohinder Dev Singh, et al.
Publicado: (2014)

On the Diagnosis and Treatment of Diabetes Mellitus, with Special Reference to the Usages of Insulin
por: Todd, A. T.
Publicado: (1923)

Vale Neil McKern – Australian Insulin Receptor Scientist
por: Ward, Colin Wesley, et al.
Publicado: (2014)

The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective
por: Leelarathna, Lalantha, et al.
Publicado: (2018)

Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
por: Haahr, Hanne, et al.
Publicado: (2018)

Commentary: ATP: The crucial component of secretory vesicles: Accelerated ATP/insulin exocytosis and prediabetes
por: Duvoor, Chitharanjan, et al.
Publicado: (2017)

Insulin Resistance in Gestational Diabetes Mellitus and Its Association With Anthropometric Fetal Indices
por: Dinh Le, Tuan, et al.
Publicado: (2022)

Comparison of different criteria for diagnosis of gestational diabetes mellitus
por: Sagili, Haritha, et al.
Publicado: (2015)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Measurement of fasting salivary insulin and its relationship with serum insulin in children
por: Fabre, B, et al.
Publicado: (2012)

Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese
por: Mitsui, Rie, et al.
Publicado: (2012)

Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
por: Evans, Marc, et al.
Publicado: (2019)

Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy
por: Dündar, Bumin Nuri, et al.
Publicado: (2009)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

Pancreatic Insulin in Diabetes Mellitus
por: Turtle, John R.
Publicado: (1971)

Reproducibility and discrimination of different indices of insulin sensitivity and insulin secretion
por: Hudak, Sarah, et al.
Publicado: (2021)

Correlation of Surrogate Markers of Insulin Resistance with Fasting Insulin in Type 2 Diabetes Mellitus Patients: A Study of Malwa Population in Punjab, India
por: Kaur, Navneet, et al.
Publicado: (2021)

Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus
por: Clarke, Brigette, et al.
Publicado: (2020)

Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria
por: Brownlee, Wallace J, et al.
Publicado: (2015)

Fasting serum insulin levels and insulin resistance are associated with colorectal adenoma in Koreans
por: Kim, Eun Hee, et al.
Publicado: (2013)

Determinants of High Fasting Insulin and Insulin Resistance Among Overweight/Obese Adolescents
por: Ling, Jerri Chiu Yun, et al.
Publicado: (2016)

Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice
por: Evans, Mark, et al.
Publicado: (2019)

Evaluation of fasting plasma insulin and proxy measurements to assess insulin sensitivity in horses
por: Lindåse, Sanna, et al.
Publicado: (2021)

Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults
por: Gundogan, Kursat, et al.
Publicado: (2013)

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
por: Polman, Chris H, et al.
Publicado: (2011)

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial
por: Mathieu, Chantal, et al.
Publicado: (2018)

A Comparative Study of Metabolic Syndrome Using NCEP—ATP III and IDF Criteria in Children and Its Relationship with Biochemical Indicators in Huatusco, Veracruz, Mexico
por: Rivadeneyra-Domínguez, Eduardo, et al.
Publicado: (2023)

Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents
por: Petersen, Kitt F, et al.
Publicado: (2005)

Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
por: Obermayer, Anna, et al.
Publicado: (2022)

The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur
por: Moy, Foong Ming, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_46nvrkjk2ue4kuhmupuo08a0h4